Nasopharyngeal Secretory Antibody Response to Poliovirus Type 3 Virion Proteins Exhibit Different Specificities After Immunization with Live or Inactivated Poliovirus Vaccines
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
By using immunoblotting, neutralization, and ELISA, the development of secretory antibody responses to poliovirus type 3 virion proteins (VP1, VP2, VP3) and to intact or trypsin-treated poliovirus type 3 was studied in the nasopharyngeal secretions in groups of infants after immunization with live attenuated poliovirus vaccine (OPV), enhanced potency inactivated poliovirus vaccine (IPV-EP), or after combined vaccination with IPV-EP followed by OPV. After three doses of vaccine, infants in all vaccine groups developed similar secretory IgA response to VP1 and VP2. The antibody response to VP3 was observed in 76.5% of subjects immunized with OPV alone and approximately 60% of those immunized with IPV-EP followed by OPV. However, only 13% of those immunized with IPV-EP alone exhibited VP3-specific antibody response. Significant differences in poliovirus type 3 specific antibody activity were observed between OPV and IPV-EP immunized subjects when trypsin-treated poliovirus was used as the antigen for neutralization or for ELISA in vitro. The neutralizing antibody activity against cleaved virus was significantly higher than against whole virus in the OPV vaccinated subjects. Both neutralizing and ELISA antibody activity against cleaved virus was significantly lower than against the whole virus in IPV-EP immunized subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ogra, P. L., Karzon, D. T., Righthand, F., & MacGillivray, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196810242791701 · Cited by 397 · cited 1×
“The Salk inactivated poliovirus vaccine previously used in the US has not been regularly associated with significant mucosal immune responses [18, 19].”
BackgroundSelf-citation
Cited by
Inactivated poliovirus vaccine: Past and present experience
Murdin, A. D., Barreto, L., & Plotkin, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00211-i · Cited by 135
Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.
(1994) · Europe PMC (PubMed Central) · Cited by 70
Poliovirus-specific intestinal antibody responses coincide with decline of poliovirus excretion.
Valtanen, S., Roivainen, M., Piirainen, L., Stenvik, M., & Hovi, T. (2000) · The Journal of Infectious Diseases · doi:10.1086/315684 · Cited by 36
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
“Tests include ELISA for PV-specific IgA and neutralisation tests [55].”
MethodInactivated and live, attenuated poliovirus vaccines: mucosal immunity.
Sutter, R. W., & Patriarca, P. A. (1993) · Measles and Poliomyelitis · doi:10.1007/978-3-7091-9278-8_23 · Cited by 23
Metadata
- Authors
- Zhaori, G., Sun, M., Faden, H. S., & Ogra, P. L.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-06-01
- Volume
- 159
- Issue
- 6
- Pages
- 1018-1024
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2104577665
- Cited by
- 42
- References
- 1
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nasopharyngeal Secretory Antibody Response to Poliovirus Type 3 Virion Proteins Exhibit Different Specificities After Immunization with Live or Inactivated Poliovirus Vaccines. https://app.cochat.ai/papers/10.1093/infdis/159.6.1018
- The paper
- Zhaori, G., Sun, M., Faden, H. S., & Ogra, P. L. (1989). Nasopharyngeal Secretory Antibody Response to Poliovirus Type 3 Virion Proteins Exhibit Different Specificities After Immunization with Live or Inactivated Poliovirus Vaccines. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/159.6.1018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.